Mark C. Leavitt
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von Mark C. Leavitt
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Synageva BioPharma Corp. /Old/
Synageva BioPharma Corp. /Old/ BiotechnologyHealth Technology Synageva BioPharma's ultimate goal is to improve patient lives by providing access to breakthrough novel, next generation (i.e. significantly improved), and certain follow on protein therapeutics. Synageva's proprietary platform technologies, including SEP™, provide a number of sustainable competitive advantages for developing and commercializing these therapeutics including: high expression levels, more efficient purification processes, significantly reduced costs of production, rapid scalability, and consistency of end product. Its platform has already demonstrated its ability to produce a wide array of human therapeutic proteins including monoclonal antibodies (mAbs), cytokines, and other biotherapeutics. It has multiple compounds in development, including 2 monoclonal antibodies with enhanced ADCC activity, novel therapeutic proteins, and several cytokines including one with unique efficacy advantages. The commercialization strategy for these product candidates is designed to maximize its ability to rapidly develop and bring them to market so that they can address patients' unmet medical needs. The key elements of the strategy are to: 1. Establish partnerships to co-develop and commercialize select product candidates in large specialty markets 2. Independently develop and commercialize select novel product candidates that target high value orphan specialty markets 3. Establish partnerships to express proteins from other companies wanting to leverage the unique glycosylation advantages and other characteristics of the SEP™.
13
| Extinct | Biotechnology | 13 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Mark C. Leavitt
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Stanford University | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | Medical Specialties | Director/Board Member Director/Board Member | |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Chief Operating Officer General Counsel | |
Y-Prime LLC
Y-Prime LLC Packaged SoftwareTechnology Services Y-Prime LLC provides eClinical software and professional services. It offers patient and IP management, site monitoring, clinical outcomes, supply forecasting and professional services. The company was founded by Shawn Blackburn and Jaime Cook in 2006 and is headquartered in Malvern, PA. | Packaged Software | Director/Board Member | |
InfaCare Pharmaceutical Corp.
InfaCare Pharmaceutical Corp. BiotechnologyHealth Technology InfaCare Pharmaceutical Corp. develops and commercializes proprietary pharmaceuticals for the neonatal and pediatric patient population. It offers Stanate, a heme oxygenase inhibitor for the treatment of infantile jaundice or hyperbilirubinemia. The company was founded by Robert A. Vukovich on July 5, 2005 and is headquartered in Trevose, PA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
BIODELIVERY SCIENCES INTERNATIONAL, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
HERON THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
CV SCIENCES, INC. | Pharmaceuticals: Other | Director/Board Member | |
Faculty of Pharmaceutical Medicine | Corporate Officer/Principal | ||
The Royal College of Physicians | College/University | Corporate Officer/Principal | |
AstraZeneca, Inc.
AstraZeneca, Inc. BiotechnologyHealth Technology Part of AstraZeneca PLC, AstraZeneca, Inc. manufactures vaccines. | Biotechnology | Corporate Officer/Principal | |
American College of Clinical Pharmacology
American College of Clinical Pharmacology Miscellaneous Commercial ServicesCommercial Services The American College of Clinical Pharmacology (ACCP) is an organization that focuses on clinical pharmacology. The American company's personal data privacy policy and procedure outlines how they collect, use, share, and protect personal data from their users. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Papyrus Therapeutics, Inc.
Papyrus Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Papyrus Therapeutics, Inc. is a preclinical stage biopharma American company that focuses on developing cancer therapeutics based on a novel target, opioid-binding cell adhesion molecule (OPCML). Papyrus Therapeutics is based in Oxford, UK. The company's expertise in this target is based on years of research and multiple publications by the company's co-founder and chief scientific adviser, Professor Hani Gabra. The company was founded by Paul Blake and Hani Gabra, and Paul Blake has been the CEO since incorporation. | Miscellaneous Commercial Services | Chief Executive Officer | |
BIOCRYST PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
Rochester Christian University | College/University | Undergraduate Degree | |
Baker Bros. Advisors LP
Baker Bros. Advisors LP Investment ManagersFinance Baker Bros. Advisors LP (BBA) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Julian Baker and Felix Baker in 2000 and do-business-as Baker Brothers Investments. BBA serves as a discretionary investment advisor to pooled investment vehicles operating as private investment funds and to a managed account. | Investment Managers | Portfolio Manager-Equities | |
ACADIA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Chairman | |
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC | Pharmaceuticals: Major | Director/Board Member | |
ANNOVIS BIO, INC. | Pharmaceuticals: Major | Director/Board Member | |
The Children's Health Fund
The Children's Health Fund Medical/Nursing ServicesHealth Services The Children's Health Fund is a non-profit organization, which engages in the provision of healthcare services for kids. It offers Blue Bus, a pediatric mobile medical clinic that offers curbside checkups and treatments. The firm also supports the Terra Firma project, a program the provides healthcare, mental health support, and legal assistance for unaccompanied immigrant minors. The company was founded by Irwin E. Redlener, Karen B. Redlener, and Paul Simon in 1987 and is headquartered in New York, NY. | Medical/Nursing Services | Director/Board Member | |
Cobb-Vantress, Inc.
Cobb-Vantress, Inc. Agricultural Commodities/MillingProcess Industries Cobb-Vantress, Inc. operates a poultry research firm. It specializes in the development, production, and sale of broiler breeding stock. The company was founded in 1986 and is headquartered in Siloam Springs, AR. | Agricultural Commodities/Milling | Corporate Officer/Principal | |
Lord Abbett Credit Opportunities Fund
Lord Abbett Credit Opportunities Fund Investment Trusts/Mutual FundsMiscellaneous Lord Abbett Credit Opportunities Fund is a closed-end management investment company that continuously offers its common shares and is operated as an interval fund. The company was founded on September 18, 2018 and is Headquartered in Jersey City, NJ. | Investment Trusts/Mutual Funds | Chairman | |
Tullis Dickerson & Co., Inc. | Chief Executive Officer | ||
CRANE COMPANY | Aerospace & Defense | Director/Board Member | |
Palm Beach Gardens, FL | Real Estate Development | Chairman | |
University of Calgary | College/University | Doctorate Degree | |
Medarex, Inc.
Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
University of Georgia | College/University | Undergraduate Degree | |
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Protez Pharmaceuticals, Inc.
Protez Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Protez Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. It develops antibiotics for infections & provides research service on intravenous & oral small molecule antibiotics to chronic and recurrent infections. The company was founded by Klaus Esser, Luigi Xerri & Christopher M. Cashman in 2003 and is headquartered in Malvern, PA. | Pharmaceuticals: Major | Director/Board Member | |
AETERNA ZENTARIS INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
University of London | College/University | Doctorate Degree | |
Memory Pharmaceuticals Corp.
Memory Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Memory Pharmaceuticals Corp. develops pharmaceutical products for the treatment of debilitating central nervous system (CNS) disorders such as Alzheimer's disease and schizophrenia. The company was founded by Axel Unterbeck in 1998 and is headquartered in Montvale, NJ. | Pharmaceuticals: Major | Director/Board Member | |
OXFORD BIOMEDICA PLC | Biotechnology | Corporate Officer/Principal | |
TSCAN THERAPEUTICS, INC. | Biotechnology | Chairman | |
Vivelix Pharmaceuticals, Ltd.
Vivelix Pharmaceuticals, Ltd. Pharmaceuticals: MajorHealth Technology Vivelix Pharmaceuticals, Ltd. manufactures and sells pharmaceutical products. The private company is based in Hamilton, BM. and has subsidiaries in the United States. The Bermudian company was founded by William P. Forbes. | Pharmaceuticals: Major | Director/Board Member | |
Notch Therapeutics, Inc.
Notch Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Notch Therapeutics, Inc. engages in the development of cell therapies for the treatment of diseases. It offers technology platform, which uses genetically tailored stem cells as a renewable source for creating allogeneic T cell therapies that expand treatment options and deliver cell immunotherapies to patients. The company was founded by Juan Carlos Zuniga-Pflucker and Peter Zandstra in 2018 and is headquartered in Toronto, Canada. | Pharmaceuticals: Other | Director/Board Member | |
The Wharton School of the University of Pennsylvania | College/University | Graduate Degree | |
Javelin Pharmaceuticals, Inc.
Javelin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Javelin Pharmaceuticals, Inc. develops pharmaceutical drugs. It is a specialty pharmaceutical company that applies innovative proprietary technologies to develop new drugs and improved formulations of existing drugs that target current unmet and underserved medical market. The company's product candidates address the acute moderate-to-severe pain medication market segment. It has three late stage product candidates in development: Dyloject (diclofenac sodium, injectable), Rylomine (intranasal morphine) and PMI-150 (intranasal ketamine). The company was founded on February 23, 1998 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Sarnoff Corp.
Sarnoff Corp. Miscellaneous Commercial ServicesCommercial Services Sarnoff Corp. provides contract research services in the fields of electronics, biomedicine and information technology. Its areas of research include optoelectronics, genomics, digital video, lasers and wireless communications. The company was founded in 1942 and is headquartered in Princeton, NJ. | Miscellaneous Commercial Services | Director/Board Member | |
Health Care Services, Inc.
Health Care Services, Inc. Medical DistributorsDistribution Services Health Care Services, Inc. provides a range of healthcare services including home medical equipment, home infusion services, home care, and rehabilitation services. The private company is based in Augusta, GA. | Medical Distributors | Director/Board Member | |
Clemson University | College/University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 40 |
Vereinigtes Königreich | 5 |
Kanada | 5 |
Irland | 2 |
Bermuda | 2 |
Sektoral
Health Technology | 24 |
Consumer Services | 9 |
Commercial Services | 6 |
Finance | 4 |
Process Industries | 3 |
Operativ
Director/Board Member | 87 |
Corporate Officer/Principal | 39 |
Independent Dir/Board Member | 29 |
Chairman | 15 |
Undergraduate Degree | 10 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Srini Akkaraju Akkaraju | 55 |
James Tullis | 32 |
Paul Blake | 23 |
Stephen Biggar | 13 |
Jeffrey Wasserstein | 11 |
John Taylor | 11 |
James E. Early | 6 |
Robyn Samuels | 6 |
Brian Conner | 6 |
Marc G. Corrado | 4 |
A. J. Joshi | 4 |
Yashwant M. Deo | 3 |
Chris Oliver | 3 |
- Börse
- Insiders
- Mark C. Leavitt
- Unternehmensverbindungen